Literature DB >> 11834004

Evaluating routine diuretics after coronary surgery: a prospective randomized controlled trial.

Eric Lim1, Ziad A Ali, Robert Attaran, Graham Cooper.   

Abstract

BACKGROUND: Routine diuretic administration after cardiopulmonary bypass is common despite the lack of evidence for its benefit. We performed a prospective study to evaluate if diuretics assist in weight loss or alter clinical outcome.
METHODS: Seventy-nine patients undergoing primary elective coronary bypass surgery were randomized to either diuretic (fusemide and amiloride) or placebo (lactose) postoperatively until preoperative weight was achieved or for 5 days in total. Proportions were compared with chi2 or Fisher's exact test.
RESULTS: Forty patients were randomized to diuretics and 39 to placebo. By day 5, 97% of patients (37 of 38) still in the diuretic arm, and 74% of patients (29 of 39) in the placebo arm, achieved preoperative weight (p = 0.02). There were no differences in clinical outcomes.
CONCLUSIONS: Routine diuretics promote an earlier diuresis but no clinical benefits are apparent in low risk patients with normal renal function. Clinicians should reconsider routine diuretic prescription in this setting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834004     DOI: 10.1016/s0003-4975(01)03311-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Sheep (Ovis aries) as a model for cardiovascular surgery and management before, during, and after cardiopulmonary bypass.

Authors:  Louis DiVincenti; Robin Westcott; Candice Lee
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

Review 2.  Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients?

Authors:  Ajay Gandhi; Mubassher Husain; Kareem Salhiyyah; Shahzad G Raja
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-03

3.  Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial.

Authors:  Hiroyuki Nishi; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Masashi Kawamura; Daisuke Yoshioka; Tetsuya Saito; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal:  Surg Today       Date:  2015-09-28       Impact factor: 2.549

Review 4.  Interventions for protecting renal function in the perioperative period.

Authors:  Mathew Zacharias; Mohan Mugawar; G Peter Herbison; Robert J Walker; Karen Hovhannisyan; Pal Sivalingam; Niamh P Conlon
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

5.  Prevention and Treatment of Cardiac Surgery Associated Acute Kidney Injury.

Authors:  Hao Cheng; Jian-Zhong Sun; Fu-Hai Ji; Hong Liu
Journal:  J Anesth Perioper Med       Date:  2016-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.